華能國際(600011.SH):3億美元境外債券將於2月21日或前後掛牌聯交所
格隆匯2月20日丨華能國際(600011.SH)公佈,2020年2月20日,公司向境外全資子公司Sinosing Services Pte.Ltd.提供擔保,並以境外全資子公司Sinosing Services Pte. Ltd.(“發行人”)為發行主體,完成了金額為3億美元、票面利率為2.250%、2025年到期的美元債券及金額為3億美元、票面利率為2.625%、2030年到期的美元債券的發行。發行人已向香港聯交所申請批准此次債券僅以向專業投資者發行債券的方式於香港聯交所上市及買賣。此次債券的上市及買賣將於2020年2月21日或前後生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.